Gabelli healthcare & wellnessrx trust sees $141,951 stock purchase by Saba capital

Published 14/01/2025, 23:48
Gabelli healthcare & wellnessrx trust sees $141,951 stock purchase by Saba capital

Saba Capital Management, L.P., a significant stakeholder in Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), recently acquired an additional 14,833 shares of common stock. The transaction, dated January 10, 2025, was executed at a price of $9.57 per share, amounting to a total purchase value of $141,951. Following this acquisition, Saba Capital's total holdings in the trust stand at 1,925,867 shares. This transaction reflects the ongoing investment activities of Saba Capital, led by Boaz Weinstein, who holds a ten percent ownership stake in the trust valued at approximately $152.16 million by market capitalization. InvestingPro analysis reveals the trust generally trades with low price volatility, with several additional insights available to subscribers.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.